Please use this identifier to cite or link to this item:
https://hdl.handle.net/10923/17876
| Type: | Article |
| Title: | The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels |
| Author(s): | WERUTSKY, GUSTAVO
MALUF, FERNANDO COTAIT
CRONEMBERGER, EDUARDO HENRIQUE
CARRERA SOUZA, VINICIUS
DOS SANTOS MARTINS, SUELEN PATRICIA
PEIXOTO, FÁBIO
SMALETZ, OREN
SCHUTZ, FÁBIO
HERCHENHORN, DANIEL
SANTOS, TELMA
MAVIGNIER CARCANO, FLAVIO
QUEIROZ MUNIZ, DAVID
NUNES FILHO, PAULO R. S.
ZAFFARONI, FACUNDO
BARRIOS, CARLOS
André Poisl Fay |
| In: | BMC CANCER |
| Issue Date: | 2019 |
| Volume: | 19 |
| Issue: | 1 |
| First page: | 487 |
| URI: | https://hdl.handle.net/10923/17876 |
| DOI: | DOI:10.1186/s12885-019-5709-y |
| ISSN: | 1471-2407 |
| Appears in Collections: | Artigo de Periódico
|
All Items in PUCRS Repository are protected by copyright, with all rights reserved, and are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Read more.
